Respiratory syncytial virus trials and beyond

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1363-1365
Number of pages	3
Journal	The Lancet Infectious Diseases
Volume	15
Issue number	12
DOIs	https://doi.org/10.1016/S1473-3099(15)00304-7
Publication status	Published - Dec 2015

Keywords

@article{73549254f2a5464081c827547913634c,

title = "Respiratory syncytial virus trials and beyond",

keywords = "PALIVIZUMAB PROPHYLAXIS, PRETERM INFANTS, MOTAVIZUMAB, CHILDREN",

author = "Mazur, \{Natalie I.\} and \{van Delden\}, \{Johannes J. M.\} and Bont, \{Louis J.\}",

year = "2015",

month = dec,

doi = "10.1016/S1473-3099(15)00304-7",

language = "English",

volume = "15",

pages = "1363--1365",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - Respiratory syncytial virus trials and beyond

AU - Mazur, Natalie I.

AU - van Delden, Johannes J. M.

AU - Bont, Louis J.

PY - 2015/12

Y1 - 2015/12

KW - PALIVIZUMAB PROPHYLAXIS

KW - PRETERM INFANTS

KW - MOTAVIZUMAB

KW - CHILDREN

U2 - 10.1016/S1473-3099(15)00304-7

DO - 10.1016/S1473-3099(15)00304-7

M3 - Comment/Letter to the editor

SN - 1473-3099

VL - 15

SP - 1363

EP - 1365

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 12

ER -